Related content

Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients

By  

Medical Principles and Practice, Vol. 24, Iss. 5, 2015-06 ,pp. : 424-431

Karger

Access to resources Recommend Favorite

Atorvastatin and the plasma activities of lipoprotein lipase, hepatic lipase and lecithin:cholesterol acyltransferase in patients with mixed hyperlipidemia

By Heller F.R.   Descamps O.S.   Hondekijn J.C.   Desager J.P.  

European Journal of Internal Medicine, Vol. 11, Iss. 1, 2000-02 ,pp. : 33-38

Elsevier

Access to resources Recommend Favorite

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis

By Viigimaa Margus   Abina Jelena   Zemtsovskaya Galina   Tikhaze Alla   Konovalova Galina   Kumskova Elena   Lankin Vadim  

Blood Pressure, Vol. 19, Iss. 3, 2010-06 ,pp. : 164-168

Informa Healthcare

Access to resources Recommend Favorite

Increased Plasma Malondialdehyde in Patients with Viral Cirrhosis and Its Relationships to Plasma Nitric Oxide, Endotoxin, and Portal Pressure

By Lee Kuei-Chuan   Yang Ying-Ying   Wang Ying-Wen   Lee Fa-Yauh   Loong Che-Chuan   Hou Ming-Chih   Lin Han-Chieh   Lee Shou-Dong  

Digestive Diseases and Sciences, Vol. 55, Iss. 7, 2010-07 ,pp. : 2077-2085

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies

By Ben Mansour R   Lassoued S   Elgaied A   Haddouk S   Marzouk S   Bahloul Z   Masmoudi H   Attia H   Aïfa MS   Fakhfakh F  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 3, 2010-05 ,pp. : 247-253

Informa Healthcare

Access to resources Recommend Favorite